This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: The Hospital for Sick Children, University of Toronto. Active years: 2025.
Company Filing History:
1 out of 167 
1 out of 529 
Years Active: 2025
Title: Anthony Semesi: Innovator in Nanoparticle Technology
Introduction
Anthony Semesi is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of nanoparticle technology, particularly in the area of antibody and vaccine delivery. His innovative work has the potential to enhance the effectiveness of medical treatments.
Latest Patents
Anthony Semesi holds a patent for a groundbreaking invention titled "Nanoparticle platform for antibody and vaccine delivery." This patent describes a fusion protein that comprises a nanocage monomer linked to an antibody or fragment thereof. The design allows for a plurality of fusion proteins to self-assemble into a nanocage, with antibodies decorating the exterior surface. This configuration ensures that the first member of a binding pair is exposed for interaction with a second member, facilitating targeted delivery in medical applications. He has 1 patent to his name.
Career Highlights
Throughout his career, Anthony has worked with prestigious institutions, including The Hospital for Sick Children and the University of Toronto. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical technology.
Collaborations
Anthony has had the opportunity to work alongside talented individuals such as Jean-Philippe Julien and Tiantian Zhao. These collaborations have further enriched his research and development efforts in nanoparticle technology.
Conclusion
Anthony Semesi is a pioneering inventor whose work in nanoparticle technology is paving the way for advancements in antibody and vaccine delivery systems. His contributions are expected to have a lasting impact on the medical field.